Effectiveness of an E-mail Tracking Intervention Among the Continued Abstinence of Tobacco Consumption (TABATIC)

Effectiveness of an E-mail Tracking Intervention Among the Continued Abstinence of Tobacco Consumption (TABATIC). A Randomized Controlled Multicentric Trial

Objectives. To evaluate the effectiveness and cost effectiveness of clinical practice guide based intervention with two face-to-face visits and e-mail tracking compared to brief advice to obtain continued smoking abstinence at 6 and 12 months after intervention.

Methodology. simple randomized controlled multicentric trial. All smokers (N=1064) aged 18 or older that attend by any reason to the primary care center and that have an e-mail account and they checked it at least once a week will be invited to participate. The enrolled participants will be randomly divided into control (N=532) and intervention group (N=532). An intensive intervention, based on the recommendations of the clinical practice guides, that will include six contacts (2 face-to-face and 4 by e-mail) will be applied to the intervention group. Control group will receive brief advice.

The main dependent variable will be continued abstinence of tobacco consumption at six and twelve months after the beginning of the intervention which will be validated by and a carbon monoxide breathe analysis measured by a cooximeter in standard conditions. Secondary variables will include: stage change on the quitting smoking process and evaluation of the effectiveness on the reduction of the number of smoked cigarettes at six and twelve months after intervention. A descriptive analysis of all variables will be done. A multivariate analysis will be undertaken to assess differences among intervention and control group; logistic regression for dichotomic variables and lineal regression for continuous variables.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

In preliminary phase is planned to carry out 2 descriptive sub-studies: a qualitative one, which will reflect the views of patients and physicians regarding the use of email as a smoking cessation intervention, and another smoker's profile in relation to Information and Communication Technologies (ICT), which collects information on the actual use of them in smokers. The result of both will help to release data on the type of participants who would be involved in the clinical trial.

Study Type

Interventional

Enrollment (Anticipated)

1064

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08007
        • Jordi Gol i Gurina Foundation. Research Unit of Barcelona. Lifestyles Research Group.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Smokers over 18 years old with an e-mail account who use frequently. (Smoker is an individual who smokes any amount of tobacco, whatever this amount it is.
  • E-mail regular user is the one who uses it as a way of communication at least once per week)

Exclusion Criteria:

  • Not regular e-mail users,
  • patients who have diseases that advise not to stop smoking:
  • Terminal diseases
  • Serious psychiatric disorders
  • Active addiction to other psychoactive drugs
  • Patients in smoking cessation process
  • whatever the cause that does not allow to understand goals and methodology of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: electronic mail
Some e-mail will be sent to participants who will be in the intervention group in order to intensify the brief advise received for stop smoking.
Other Names:
  • e-mail, electronic mail, computer intervention,
No Intervention: brief advise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in smoking status and maintenance in smoking cessation
Time Frame: the outcome measure is studied at 6 and 12 months
The term used to name long term abstinence over 6 months is continuous abstinence.
the outcome measure is studied at 6 and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
point prevalence abstinence
Time Frame: the outcome measure is studied at 3, 6 and 12 months
In case ok not reaching abstinence, will be measured if a subject has changed of stage in "transtheoretical model of Prochaska and DiClemente".
the outcome measure is studied at 3, 6 and 12 months
self-reported tobacco consumption
Time Frame: the outcome measure is studied at 3, 6 and 12 months
the outcome measure is studied at 3, 6 and 12 months
self-reported smoking reduction
Time Frame: the outcome measure will be studied at 3, 6 and 12 months
In case not reaching abstinence
the outcome measure will be studied at 3, 6 and 12 months
stage of change in Prochaska cycle
Time Frame: the outcome measure will be studied at 3,6 and 12 months
the outcome measure will be studied at 3,6 and 12 months
used time by professionals to achieve patients stop smoking
Time Frame: the outcome measure will be studied at 3, 6 and 12 months
the outcome measure will be studied at 3, 6 and 12 months
used time by participants
Time Frame: the outcome measure will be studied at 3, 6 and 12 months
the outcome measure will be studied at 3, 6 and 12 months
cost to get smoking help in primary care service
Time Frame: the outcome measure will be studied at 3, 6 and 12 months
The estimated cost of helping people to leave smoking in regular conditions
the outcome measure will be studied at 3, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: José L Ballvé Moreno, MD, Institut Català de la Salut
  • Study Chair: Marc Casajuana, Economist, IDIAP Jordi Gol
  • Study Chair: Lourdes Clemente, MD, Servicio Aragones De Salud
  • Principal Investigator: Laura Díaz Gete, MD, Institut Català de la Salut
  • Study Chair: Elena M Briones Carrió, Statistician, IDIAP Jordi Gol
  • Study Chair: Mireia Fàbregas Escurriola, MD, Institut Català de la Salut
  • Study Chair: Elisa Puigdomènech Puig, Byologist, IDIAP Jordi Gol
  • Study Chair: José L del Val, MD, Institut Català de la Salut
  • Study Chair: Soraya Fernández Maestre, nurse, Institut Català de la Salut
  • Study Chair: Carlos Martín Cantera, MD, Ph D, Institut Català de la Salut. Research Unit of Barcelona, IDIAP Jordi Gol. Department of Medicine, University Autonomus of Barcelona
  • Study Chair: Ricardo Almon, MD, PhD, Family Medicine Research centre School of Health and medical Sciences. Örebro University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Primary Completion (Actual)

September 1, 2013

Study Completion (Anticipated)

December 1, 2014

Study Registration Dates

First Submitted

November 30, 2011

First Submitted That Met QC Criteria

December 15, 2011

First Posted (Estimate)

December 16, 2011

Study Record Updates

Last Update Posted (Estimate)

June 19, 2014

Last Update Submitted That Met QC Criteria

June 18, 2014

Last Verified

June 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tobacco Dependence

Clinical Trials on electronic mail

3
Subscribe